Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics.

Holzapfel W, Arini A, Aeschbacher M, Coppolecchia R, Pot B

Open source

DOI
10.3920/bm2017.0148
Published
2018 Apr 25
Container
Beneficial microbes
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3920/bm2017.0148,
  title = {Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics.},
  author = {Holzapfel W and Arini A and Aeschbacher M and Coppolecchia R and Pot B},
  year = {2018},
  journal = {Beneficial microbes},
  doi = {10.3920/bm2017.0148},
  url = {https://doi.org/10.3920/bm2017.0148}
}

RIS

TY  - JOUR
TI  - Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics.
AU  - Holzapfel W
AU  - Arini A
AU  - Aeschbacher M
AU  - Coppolecchia R
AU  - Pot B
PY  - 2018
JO  - Beneficial microbes
DO  - 10.3920/bm2017.0148
UR  - https://doi.org/10.3920/bm2017.0148
ER  - 

APA

W, H., A, A., M, A., R, C., & B, P. (2018). Enterococcus faecium SF68 as a model for efficacy and safety evaluation of pharmaceutical probiotics.. Beneficial microbes. https://doi.org/10.3920/bm2017.0148

Source records